U.S. Market Morning Recap | September 26

Cat Investor view
09-26

1. Macro Drivers

Tariff Overhang – Trump announced new tariffs, set to take effect in October, covering drugs, heavy trucks and furniture. Healthcare and biotech names were hit hardest.

Cooling Rate-Cut Hopes – Stronger-than-expected durable goods and labor data trimmed expectations for a year-end Fed cut.

Key Data Ahead – Core PCE inflation prints later today; markets are bracing for a directional catalyst.

2. Market Performance

Indices – S&P 500 opened down about 0.5%, Nasdaq lower by 0.4%, both trading in a choppy, risk-off tone.

Sector Moves –

Healthcare/Biotech: leading laggards on tariff headlines

Tech/Semiconductors: valuation pressure rising as yields stay firm

Utilities/Energy/Infrastructure: relative resilience, attracting defensive flows

3. Stock Highlights

NVIDIA (NVDA) – Remains the bellwether for AI and semis; rich multiples make it hypersensitive to rate and sentiment swings.

Apple (AAPL) – Steady fundamentals, but difficult to decouple from broader tech weakness.

Microsoft (MSFT) – Cloud and software revenues provide some downside cushion, though valuation still leaves little room for error.

Alliant Energy (LNT) – Classic defensive play in utilities; stable demand and dividend support make it a hedge in volatile markets.

4. Strategy Takeaways

Near Term – Wait for the PCE release before committing capital. A softer read could set up a tactical bounce in tech; a hot print would argue for staying defensive.

Medium Term – The AI/tech growth story is intact, but entry points matter. Favor high-quality names with strong cash flow and pricing power.

Defensive Balance – Keep a portion of the portfolio in utilities and essential infrastructure to buffer policy or data shocks.

Risk Discipline – Stay nimble. Define stops and profit-taking levels to manage volatility driven by policy headlines and inflation surprises.

Market Down 3 Days! Valuations Too High: Would You Hedge?
U.S. stocks have fallen for three consecutive days, with all three major indexes giving back their post-Fed September meeting gains. Strong economic data has added uncertainty to the future rate-cut path, while tech giants continue to show weakness. 1. Do you think this is a healthy pullback? 2. Do you agree with Powell that U.S. equities are overvalued? 3. Can upcoming earnings season justify the current lofty valuations? 4. Would you choose to take some profits or fully hedge your portfolio?
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment